Social Cognition Impairments in 22q11.2DS Individuals With and Without Psychosis: A Comparison Study With a Large Population of Patients With Schizophrenia.

Tommaso Accinni, Antonino Buzzanca, Marianna Frascarelli, Luca Carlone, Francesco Ghezzi, Georgios D Kotzalidis, Paola Bucci, Giulia Maria Giordano, Nicoletta Girardi, Alessia Panzera, Simone Montaldo, Martina Fanella, Carlo Di Bonaventura, Carolina Putotto, Paolo Versacci, Bruno Marino, Massimo Pasquini, Massimo Biondi, Fabio Di Fabio
Author Information
  1. Tommaso Accinni: Department of Human Neurosciences, Sapienza University of Rome, Faculty of Medicine and Dentistry, Rome, Italy.
  2. Antonino Buzzanca: Department of Human Neurosciences, Sapienza University of Rome, Faculty of Medicine and Dentistry, Rome, Italy.
  3. Marianna Frascarelli: Department of Human Neurosciences, Sapienza University of Rome, Faculty of Medicine and Dentistry, Rome, Italy. ORCID
  4. Luca Carlone: Department of Human Neurosciences, Sapienza University of Rome, Faculty of Medicine and Dentistry, Rome, Italy.
  5. Francesco Ghezzi: Department of Human Neurosciences, Sapienza University of Rome, Faculty of Medicine and Dentistry, Rome, Italy.
  6. Georgios D Kotzalidis: Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University, Faculty of Medicine and Psychology, Rome, Italy.
  7. Paola Bucci: Department of Psychiatry, Campania University "Luigi Vanvitelli," Naples, Italy.
  8. Giulia Maria Giordano: Department of Psychiatry, Campania University "Luigi Vanvitelli," Naples, Italy.
  9. Nicoletta Girardi: Department of Human Neurosciences, Sapienza University of Rome, Faculty of Medicine and Dentistry, Rome, Italy.
  10. Alessia Panzera: Department of Human Neurosciences, Sapienza University of Rome, Faculty of Medicine and Dentistry, Rome, Italy.
  11. Simone Montaldo: Department of Human Neurosciences, Sapienza University of Rome, Faculty of Medicine and Dentistry, Rome, Italy.
  12. Martina Fanella: Department of Human Neurosciences, Sapienza University of Rome, Faculty of Medicine and Dentistry, Rome, Italy.
  13. Carlo Di Bonaventura: Department of Human Neurosciences, Sapienza University of Rome, Faculty of Medicine and Dentistry, Rome, Italy.
  14. Carolina Putotto: Department of Pediatrics, Sapienza Univerisity of Rome, Rome, Italy.
  15. Paolo Versacci: Department of Pediatrics, Sapienza Univerisity of Rome, Rome, Italy.
  16. Bruno Marino: Department of Pediatrics, Sapienza Univerisity of Rome, Rome, Italy.
  17. Massimo Pasquini: Department of Human Neurosciences, Sapienza University of Rome, Faculty of Medicine and Dentistry, Rome, Italy.
  18. Massimo Biondi: Department of Human Neurosciences, Sapienza University of Rome, Faculty of Medicine and Dentistry, Rome, Italy.
  19. Fabio Di Fabio: Department of Human Neurosciences, Sapienza University of Rome, Faculty of Medicine and Dentistry, Rome, Italy.

Abstract

Background: 22q11.2 Deletion Syndrome (22q11DS) represents one of the most important genetic risk factors for schizophrenia (SCZ) and a reliable biological model to study endophenotypic characters of SCZ. The aim of the study was to investigate Social Cognition impairments in subjects with 22q11.2DS compared to a considerable sample of schizophrenic patients.
Methods: Forty-four individuals with 22q11.2DS (DEL) and 18 patients with 22q11.2DS and psychosis (DEL_SCZ) were enrolled; these groups were compared to 887 patients with schizophrenia (SCZ) and 780 healthy controls (HCs); the latter groups were recruited by the Italian Network for Research on Psychoses (NIRP) to which our Centre took part. Social cognition was evaluated through The Awareness of Social Inference Test (TASIT). A resampling procedure was employed to balance differences in samples size.
Results: All clinical groups (DEL; DEL_SCZ; and SCZ) showed worse performance on TASIT than HCs, except in scale. No differences between-clinical groups were found, except for and scales.
Conclusions: SC was impaired in individuals with 22q11.2DS regardless of psychotic symptomatology, similarly to people with SCZ. Therefore, SC deficits may represent potential endophenotypes of SCZ contributing to the vulnerability to psychosis.

Keywords

References

  1. Nat Rev Dis Primers. 2015 Nov 19;1:15071 [PMID: 27189754]
  2. Schizophr Res. 2019 Jun;208:76-81 [PMID: 31056275]
  3. Early Interv Psychiatry. 2019 Apr;13(2):169-180 [PMID: 29938910]
  4. Psychol Med. 2018 Jun;48(8):1359-1366 [PMID: 29017620]
  5. J Child Psychol Psychiatry. 2006 Mar-Apr;47(3-4):296-312 [PMID: 16492261]
  6. Schizophr Res. 2017 Dec;190:11-17 [PMID: 28302393]
  7. World Psychiatry. 2020 Feb;19(1):81-91 [PMID: 31922687]
  8. Acta Psychiatr Scand. 2018 Sep;138(3):253-266 [PMID: 29984409]
  9. Psychiatry Res. 2014 Aug 15;218(1-2):39-43 [PMID: 24755041]
  10. Neuroimage Clin. 2019;24:101987 [PMID: 31446315]
  11. Eur Neuropsychopharmacol. 2016 Oct;26(10):1610-8 [PMID: 27524298]
  12. Behav Brain Funct. 2017 Feb 16;13(1):4 [PMID: 28209179]
  13. J Nerv Ment Dis. 2016 Mar;204(3):240-3 [PMID: 26919303]
  14. Br J Psychiatry. 2019 Feb;214(2):103-112 [PMID: 30139394]
  15. Am J Psychiatry. 2008 Feb;165(2):214-20 [PMID: 18172018]
  16. Br J Psychiatry. 2006 Dec;189:560-1 [PMID: 17139043]
  17. Schizophr Bull. 2005 Jan;31(1):21-42 [PMID: 15888423]
  18. Mol Psychiatry. 2014 Nov;19(11):1205-11 [PMID: 24445907]
  19. Psychiatry Res. 2018 May;263:185-192 [PMID: 29573658]
  20. JAMA Psychiatry. 2020 Jul 1;77(7):755-765 [PMID: 32159746]
  21. Psychol Med. 2004 Apr;34(3):385-9 [PMID: 15259823]
  22. Behav Genet. 2018 Jul;48(4):259-270 [PMID: 29922984]
  23. Eur Child Adolesc Psychiatry. 2014 Jun;23(6):425-36 [PMID: 23999732]
  24. Schizophr Res. 2012 Dec;142(1-3):99-107 [PMID: 23122739]
  25. Psychol Med. 2009 Apr;39(4):645-54 [PMID: 18694537]
  26. Cognition. 2000 Jul 14;76(1):59-90 [PMID: 10822043]
  27. Int J Mol Sci. 2017 May 18;18(5): [PMID: 28524075]
  28. Genome Res. 2019 Sep;29(9):1389-1401 [PMID: 31481461]
  29. J Int Neuropsychol Soc. 2018 Oct;24(9):905-916 [PMID: 30375321]
  30. J Pediatr. 2005 Jul;147(1):90-6 [PMID: 16027702]
  31. Schizophr Res. 2013 Aug;148(1-3):175-80 [PMID: 23773297]
  32. J Neurodev Disord. 2021 Apr 17;13(1):15 [PMID: 33863277]
  33. J Neurodev Disord. 2011 Jun;3(2):152-61 [PMID: 21544568]
  34. Am J Psychiatry. 2008 Feb;165(2):203-13 [PMID: 18172019]
  35. Psychol Med. 2016 Oct;46(13):2717-29 [PMID: 27649341]
  36. Biol Psychiatry. 2008 Jan 1;63(1):49-57 [PMID: 17651704]
  37. Psychiatry Res. 2010 May 15;177(1-2):211-5 [PMID: 20381171]
  38. Schizophr Bull. 2019 Sep 11;45(5):1033-1041 [PMID: 30256991]
  39. Schizophr Bull. 1987;13(2):261-76 [PMID: 3616518]
  40. Wiley Interdiscip Rev Dev Biol. 2013 May-Jun;2(3):393-403 [PMID: 23799583]
  41. Int J Dev Neurosci. 2011 May;29(3):259-81 [PMID: 20920576]
  42. Am J Med Genet A. 2005 Nov 1;138(4):307-13 [PMID: 16208694]
  43. Schizophr Res. 2019 Apr;206:386-393 [PMID: 30414720]
  44. World Psychiatry. 2019 Jun;18(2):146-161 [PMID: 31059632]
  45. Eur Arch Psychiatry Clin Neurosci. 2017 Jun;267(4):285-294 [PMID: 27381016]
  46. BMC Psychiatry. 2021 Mar 6;21(1):130 [PMID: 33676445]
  47. Psychiatry Res. 2006 Sep 30;144(1):29-37 [PMID: 16904190]
  48. Pediatrics. 2003 Jul;112(1 Pt 1):101-7 [PMID: 12837874]
  49. J Am Acad Child Adolesc Psychiatry. 2010 Apr;49(4):333-44 [PMID: 20410726]
  50. World Psychiatry. 2016 Oct;15(3):259-265 [PMID: 27717277]
  51. JAMA Psychiatry. 2018 Jul 1;75(7):754-755 [PMID: 29799938]
  52. J Am Acad Child Adolesc Psychiatry. 2006 Sep;45(9):1104-1113 [PMID: 16926618]
  53. Schizophr Res. 2006 Oct;87(1-3):270-8 [PMID: 16753283]
  54. Schizophr Res. 2017 Oct;188:59-62 [PMID: 28119035]
  55. Lancet. 2002 Feb 2;359(9304):426-30 [PMID: 11844533]
  56. Actas Esp Psiquiatr. 2017 Sep;45(5):218-26 [PMID: 29044446]
  57. Am J Psychiatry. 2003 Apr;160(4):636-45 [PMID: 12668349]
  58. Disabil Rehabil. 2006 Dec 30;28(24):1529-42 [PMID: 17178616]
  59. Schizophr Bull. 2017 Jul 1;43(4):833-842 [PMID: 27798222]
  60. JAMA Psychiatry. 2015 Apr;72(4):377-85 [PMID: 25715178]
  61. Am J Psychiatry. 2003 Sep;160(9):1580-6 [PMID: 12944331]
  62. J Neurosci Res. 2018 Oct;96(10):1631-1640 [PMID: 30004142]
  63. Front Psychiatry. 2019 Sep 18;10:666 [PMID: 31616325]
  64. Schizophr Res. 2013 Mar;144(1-3):31-6 [PMID: 23347949]

Word Cloud

Created with Highcharts 10.0.022q11SCZ2DSSocialgroupsschizophreniapatientspsychosis2studyCognitioncomparedindividualsDELDEL_SCZHCsItalianNetworkResearchPsychosescognitionTASITdifferencesexceptSCsocialBackground:DeletionSyndrome22q11DSrepresentsoneimportantgeneticriskfactorsreliablebiologicalmodelendophenotypiccharactersaiminvestigateimpairmentssubjectsconsiderablesampleschizophrenicMethods:Forty-four18enrolled887780healthycontrolslatterrecruitedNIRPCentretookpartevaluatedAwarenessInferenceTestresamplingprocedureemployedbalancesamplessizeResults:clinicalshowedworseperformancescalebetween-clinicalfoundscalesConclusions:impairedregardlesspsychoticsymptomatologysimilarlypeopleThereforedeficitsmayrepresentpotentialendophenotypescontributingvulnerabilityImpairmentsIndividualsWithoutPsychosis:ComparisonStudyLargePopulationPatientsSchizophreniadeletionsyndromeneurocognitioninferencetheorymind

Similar Articles

Cited By